Viewing StudyNCT00322348



Ignite Creation Date: 2024-05-05 @ 4:49 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00322348
Status: COMPLETED
Last Update Posted: 2011-01-24
First Post: 2006-05-03

Brief Title: Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer ABC Pre-menopausal Women
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Advanced Breast Cancer
Keywords:
Name View
breast cancer View
oncology View
cancer View